REVIVA PHARMACEUTICALS HOLDINGS, INC.

Reviva Pharmaceuticals Holdings, Inc., trading under the SPAC ticker TZAC, filed a Form 10-Q with the SEC on October 8, 2019, with accession number 0001144204-19-047666. TZAC operated as a blank-check company targeting the pharmaceutical and biotechnology sector, reflecting the period's active deal flow in healthcare-focused SPACs. The filing represents a quarterly disclosure made during the SPAC's active search phase or transitional period, as the vehicle pursued a combination within the life sciences industry. The sponsor information associated with this vehicle is available in full within SpacDesk's filing database. Visit SpacDesk to sign up for complete sponsor profiles, filing timelines, and deal-status tracking on TZAC and hundreds of other SPAC vehicles.